8-OH DPAT can restore the locomotor stimulant effects of cocaine blocked by haloperidol

Pharmacology Biochemistry and Behavior

Volumn 66, Issue 4, 2000, Pages 863-872

  Carey, Robert ^a   Damianopoulos, Ernest ^a   De Palma, Gail ^a  

^a SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

Author keywords

8 OH DPAT; Central zone; Cocaine; Haloperidol; Locomotion

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; COCAINE; HALOPERIDOL;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CATALEPSY; CONTROLLED STUDY; DOPAMINE METABOLISM; LOCOMOTION; MALE; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONIN METABOLISM; STIMULATION;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ANIMALS; ANTIPSYCHOTIC AGENTS; BRAIN CHEMISTRY; COCAINE; DOPAMINE; DOPAMINE UPTAKE INHIBITORS; HALOPERIDOL; MALE; MOTOR ACTIVITY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1; SEROTONIN; SEROTONIN AGONISTS; STIMULATION, CHEMICAL; TIME FACTORS;

EID: 0033888289     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(00)00290-2     Document Type: Article

References (46)

1. Anderson H.L., Kilpatrick I.C. Prevention by (±)-8-hydroxy-2-(di-n-propylamino) tetralin of both catalepsy and the rises in rat striatal dopamine metabolism caused by haloperidol. Br. J. Pharmacol. 118:1996;421-427.
2. Borowsky B., Kuhn C.M. Chronic cocaine administration sensitizes behavioral but not neuroendocrine responses. Brain Res. 543:1991;301-306.
3. Cabib S., Castellano C., Cestari V., Filibeck U. Puglisi-Allegra, S. D1 and D2 receptor antagonists differently affect cocaine-induced locomotor hyperactivity in the mouse Psychopharmacology (Berlin). 105:1991;335-339.
4. Carey R., Damianopoulos E., DePalma G. Issues in the pharmacological modification of cocaine conditioning. Evidence that the stimulus properties of drugs can interact with contextual cues to activate or inactivate cocaine conditioned stimuli Behav. Brain Res. 101:1999;189-206.
5. Carey R.J., Damianopoulos E.N. Cocaine stimulant effects. Role of 5-HT1A receptors Soc. Neurosci. Abstr. 24:1998;2170-2171.
6. Carey R.J., DePalma G. A simple, rapid HPLC method for the concurrent measurement of cocaine and catecholamines in brain tissue samples. J. Neurosci. Methods. 58:1995;25-28.
7. Carey R.J., Gui J. A simple and reliable method for the positive identification of Pavlovian conditioned cocaine effects in open-field behavior. J. Neurosci. Methods. 73:1997;1-8.
8. Chessalet M.F. Presynaptic regulation of neurotransmitter release in the brain. Facts and hypothesis Neuroscience. 12:1984;347-375.
9. Chopin P., Briley M. Animal models of anxiety. The effect of compounds that modify 5-HT neurotransmission Trends Pharmacol. Sci. 8:1987;383-388.
10. Conceicao I.M., Frussa-Filho R. Effects if a single administration of buspirone on catalepsy, yawning and sterotypy in rats. Braz. J. Med. Biol. Res. 26:1993;71-74.
11. Cunningham K.A., Lakoski J.M. The interaction of cocaine with serotonin dorsal raphe neurons. Single-unit extracellular recording studies. Neuropsychopharmacology. 3:1990;41-50.
12. Druhan J.P., Wilent A.C. Effects of the competitive N-methyl-D-aspartate receptor antagonist, CPP, on the development and expression of conditioned hyperactivity and sensitization by cocaine. Behav. Brain Res. 102:1999;195-210.
13. Fowler S.C., Liao R.M., Skjoldager P. A new rodent model for neuroleptic-induced pseudo-parkinsonism. Low doses of haloperidol increase forelimb tremor in the rat Behav. Neurosci. 104:1990;449-456.
14. Haaren F.V., Meyer M.E. Sex differences in locomotor activity after acute and chronic cocaine administration. Pharmacol. Biochem. Behav. 39:1991;923-927.
15. Hicks P.B. The effect of serotonergic agents on haloperidol-induced catalepsy. Life Sci. 47:1990;1609-1615.
16. Invernizzi R.W., Cervo L., Samanin R. 8-Hydroxy-2-(di-n-propylamino)tetralin, a selective serotonin 1A receptor agonist, blocks haloperidol-induced catalepsy by an action on raphe nuclei medianus and dorsalis. Neurophamacology. 27:1988;515-518.
17. Karolewicz B., Antkiewicz-Michaluk L., Michulak J., Vetulani J. Different effects of chronic administration of haloperidol and pimozide on dopamine metabolism in the rat brain. Eur. J. Pharmacol. 313:1996;181-186.
18. Koe B.K. Molecular geometry of inhibitors of the uptake of catecholamines and serotonin synaptosomal preparations of rat brain. J. Pharmacol. Exp. Ther. 199:1976;649-661.
19. Koob G.F. Drugs of abuse. Anatomy, pharmacology and function of reward pathways Trends Pharmacol. Sci. 13:1992;177-184. [Review].
20. Kostowski W., Plaznik A., Stefanski R. Intra-hippocampal buspirone in animal models of anxiety. Eur. J. Pharmacol. 168:1989;393-396.
21. Lee E.H.Y., Lin Y.P., Yin T.H. Effects of lateral and medial septal lesions on various activity and reactivity measures in rats. Physiol. Behav. 42:1988;97-102.
22. Liao R.M., Fowler S.C. Haloperidol produces within-session increments in operant response duration in rats. Pharmacol. Biochem. Behav. 36:1990;191-201.
23. A/C antagonist, reverse haloperidol-induced catalepsy in rats independently of striatal dopamine release. Psychopharmacology (Berlin). 131:1997;57-63.
24. Lynch M.R., Carey R.J. Within-session data. Biol. Psychiatry. 21:1986;573-574. [letter].
25. Lynch M.R., Carey R.J. Environmental stimulation promotes recovery from haloperidol-induced extinction of open field behavior in rats. Psychopharmacology (Berlin). 92:1987;206-209.
26. Lynch M.R., Kuhn H.G., Carey R.J. Chronic haloperidol-amphetamine interactions and mesolimbic dopamine. Neuropsychobiology. 19:1988;97-103.
27. Mattingly B.A., Rowlett J.K., Ellison T., Rase K. Cocaine-induced behavioral sensitization. Effects of haloperidol and SCH 23390 treatments Pharmacol. Biochem. Behav. 53:1996;481-486.
28. Millan M.J., Gobert A., Newman-Tancredi A., Audinot V., Lejeune F., Rivet J.M., Cussac D., Nicolas J.P., Muller O., Lavielle G. S 16924 ((R)-2-[1-[2-(2,3-dihydro-benzo[1,4] dioxin-5-Yloxy)-ethyl]-pyrrolidin-3yl]-1-(4-fluoro-phenyl)-ethanone), a novel, potential antipsychotic with marked serotonin (5-HT) 1A agonist properties. I. Receptorial and neurochemical profile in comparison with clozapine and haloperidol J. Pharmacol. Exp. Ther. 286:1998;1341-1355.
29. Neal-Beliveau B.S., Joyce J.N., Lucki I. Serotonergic involvement in haloperidol-induced catalepsy. J. Pharmacol. Exp. Ther. 265:1993;207-217.
30. Nowak J.Z., Arbilla S., Dahl S.G., Langer S.Z. Antogonism of presynaptic dopamine receptors by phenothiazine drug metabolites. Life Sci. 46:1990;443.
31. Oitzl M.S., de Kloet E.R. Corticosterone modulates exploration via central mineralocorticoid receptors. Soc. Neurosci. Abstr. 18:1992;718.
32. Pert A., Post R.M., Weiss S.R.B. Conditioning as a critical determinant of sensitization induced by psychomotor stimulants. NIDA Res.Monogr. 97:1990;208-240.
33. Queiroz C.M.T., Frussa-Filho R. Effects of buspirone on dopaminergic supersensitivity. Life Sci. 61:1997;371-382.
34. Rayevsky K.S., Gainetdinov R.R., Grekhova T.V., Sotnikova T.D. Regulation of dopamine release and metabolism in rat striatum in vivo. Effects of dopamine receptor antagonists Prog. Neuropsychopharmacol. Biol. Psychiatry. 19:1995;1285-1303.
35. Ritz M.C., Cone E.J., Kuhar M.J. Cocaine inhibition of ligand binding at dopamine, norepinephrine and serotonin transporters. A structure-activity study Life Sci. 46:1990;635-645.
36. Ritz M.C., Lamb R.J., Goldberg S.R., Kuhar M.J. Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science. 237:1987;1219-1223.
37. Segal D.S., Kuczenski R. Repeated cocaine administration induces behavioral sensitization and corresponding decreased extracellular dopamine responses in caudate and accumbens. Brain Res. 577:1992;351-355.
38. Sorg B.A. Mesocorticolimbic dopamine systems. Cross-sensitization between stress and cocaine Ann. NY Acad. Sci. 654:1992;136-144.
39. Stefanski R., Palejko W., Kostowski W., Plaznik A. The comparison of benzodiazepine derivatives and serotonergic agonists and antagonists in two animal models of anxiety. Neuropharmacology. 31:1992;1251-1258.
40. Stewart J., Badiani A. Tolerance and sensitization to the behavioral effects of drugs. Behav. Pharmacol. 4:1993;289-312.
41. Suzuki T., Mori T., Tsuji M., Misawa M. Interaction between discriminative stimulus effects of cocaine and morphine. Jpn. J. Pharmacol. 67:1995;341-347.
42. Tella S.R. Differential blockade of chronic versus acute effects of intravenous cocaine by dopamine receptor antagonists. Pharmacol. Biochem. Behav. 48:1994;151-159.
43. 2A antagonism of cocaine-induced facilitation of brain stimulation reward. Pharmacol. Biochem. Behav. 59:1998;275-280.
44. 1A and dopamine D2 receptor mechanisms in the mediation extrapyramidal motor functions in the rat. Pharmacol. Biochem. Behav. 47:1994;509-513.
45. Weiss S.R., Post R.M., Pert A., Woodward R., Murman D. Context-dependent cocaine sensitization. Differential effect of haloperidol on development versus expression Pharmacol. Biochem. Behav. 34:1989;655-661.
46. Woolverton W.L., Johnson K.M. Neurobiology of cocaine abuse. Trends Pharmacol. Sci. 13:1992;193-200. [Review].